Nucleolin identified by comparative mass‑spectra analysis is a potential marker for invasive progression of hepatocellular carcinoma

Mol Med Rep. 2014 Sep;10(3):1489-94. doi: 10.3892/mmr.2014.2321. Epub 2014 Jun 13.

Abstract

At present, the diagnosis and prognosis of hepatocellular carcinoma (HCC) metastasis remains poor. Recently, a number of proteins associated with the metastasis and invasion of HCC were identified; however, the effective markers require further elucidation. In the current study, a nucleolin expression was observed in MHCC97L and HCCLM9 HCC cell lines, with low and high metastatic potentials respectively, using comparative proteomics. The data indicated that nucleolin expression in the nucleus was significantly higher in HCCLM9 cells, and it primarily influenced the migration of HCC cells in vitro. Thus, to the best of our knowledge this is the first study to hypothesize that nucleolin may be a novel marker for HCC invasive progression.

MeSH terms

  • Biomarkers, Tumor / blood*
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / pathology*
  • Cell Line, Tumor
  • Cell Movement / physiology
  • Disease Progression
  • Electrophoresis, Polyacrylamide Gel
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Liver Neoplasms / genetics
  • Liver Neoplasms / pathology
  • Mass Spectrometry
  • Neoplasm Invasiveness
  • Nucleolin
  • Phosphoproteins / genetics
  • Phosphoproteins / metabolism*
  • Proteomics
  • RNA, Messenger
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism*
  • Reproducibility of Results
  • Tandem Mass Spectrometry

Substances

  • Biomarkers, Tumor
  • Phosphoproteins
  • RNA, Messenger
  • RNA-Binding Proteins